All primary cells can only be culture-expanded for a limited number of passages. In the course of culture expansion the proliferation rate decays until the cells enter a senescent state with unequivocal growth arrest after about 40 to 70 population doublings. Culture expansion is also associated with strong morphological changes, impact on the growth pattern, and loss of differentiation potential. Particularly for cellular therapy high quality cells of early passage are favorable. It is therefore of high importance to keep track of replicative senescence. Alternative methods available to estimate the state of cellular aging are not precise - they cannot discern from changes induced by aging of the organism and do not provide estimates of population doublings during culture expansion.
Cygenia provides this service to all scientists working with cells in culture - particularly to those generating therapeutic cell products which necessitate very high quality standards. The Epigenetic-Senescence-Signature has so far been validated for human fibroblasts, mesenchymal stem cells, and human umbilical endothelial cells (HUVECS). The method was trained on various different culture methods to provide robust predictions of cumulative population doublings (cPDs). This approach is also of interest for scientists who want to test the impact of specific growth factors, irradiation, hypoxia etc. on the epigenetic state of cellular aging.
Koch C, et al. Monitoring of cellular aging by DNA-methylation at specific CpG sites. Aging Cell 2012.
Koch C and Wagner W. Epigenetic Biomarker to Determine Replicative Senescence of in vitro-Cultured Cells. Methods in Molecular Biology 2013.
Patent application: 2011; EP 11176593.9